Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
5.80
-0.36 (-5.84%)
Oct 7, 2025, 11:31 AM EDT - Market open
Karyopharm Therapeutics Market Cap
Karyopharm Therapeutics has a market cap or net worth of $50.29 million as of October 7, 2025. Its market cap has decreased by -45.39% in one year.
Market Cap
50.29M
Enterprise Value
265.84M
1-Year Change
-45.39%
Ranking
Category
Stock Price
$5.80
Market Cap Chart
Since November 6, 2013, Karyopharm Therapeutics's market cap has decreased from $442.90M to $50.29M, a decrease of -88.64%. That is a compound annual growth rate of -16.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 53.40M | -36.95% |
| Dec 31, 2024 | 84.70M | -14.53% |
| Dec 29, 2023 | 99.10M | -64.08% |
| Dec 30, 2022 | 275.90M | -43.21% |
| Dec 31, 2021 | 485.80M | -57.36% |
| Dec 31, 2020 | 1.14B | -5.35% |
| Dec 31, 2019 | 1.20B | 111.62% |
| Dec 31, 2018 | 568.80M | 25.59% |
| Dec 29, 2017 | 452.90M | 16.82% |
| Dec 30, 2016 | 387.70M | -18.12% |
| Dec 31, 2015 | 473.50M | -61.32% |
| Dec 31, 2014 | 1.22B | 79.50% |
| Dec 31, 2013 | 681.90M | 53.96% |
| Nov 6, 2013 | 442.90M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 764.02B |
| Johnson & Johnson | 455.92B |
| AbbVie | 408.48B |
| UnitedHealth Group | 327.63B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 233.92B |